Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Genital Herpes Simplex Type 2”

36 trials

Showing 20 of 36 results

Post-approval studies (Phase 4)Study completedNCT00464542
What this trial is testing

Asymptomatic Bacterial Vaginosis and Herpes Simplex Virus Type 2 (BV/HSV-2) Shedding Study

Who this might be right for
Bacterial Vaginosis
University of Pittsburgh 12
Testing effectiveness (Phase 2)Study completedNCT02837575
What this trial is testing

Safety and Efficacy Study of Herpes Simplex Virus Type 2 (HSV-2) Therapeutic DNA Vaccine

Who this might be right for
Herpes Genitalis
Vical 261
Not applicableStudy completedNCT01112956
What this trial is testing

Serologic Assays for the Diagnosis of Herpes Simplex Virus Type 2

Who this might be right for
Genital Herpes
Centers for Disease Control and Prevention 2,500
Testing effectiveness (Phase 2)Study completedNCT00371592
What this trial is testing

Effectiveness of Acyclovir in Suppressing HIV Viral Load in Women Coinfected With HIV and Herpes Simplex Virus Type 2 (HSV-2)

Who this might be right for
HIV InfectionsHerpesvirus 2, Human
National Institute of Allergy and Infectious Diseases (NIAID) 50
Not applicableStudy completedNCT01043081
What this trial is testing

Sexually Transmitted Infections Among African American Women Who Have Sex With Women

Who this might be right for
Sexually Transmitted InfectionsHIV Infections
University of Mississippi Medical Center 300
Testing effectiveness (Phase 2)Study completedNCT02515175
What this trial is testing

Evaluating New Formulation of Therapeutic HSV-2 Vaccine

Who this might be right for
Genital Herpes Simplex Type 2
Genocea Biosciences, Inc. 131
Large-scale testing (Phase 3)Study completedNCT00194519
What this trial is testing

Herpes Simplex Virus Type 2 (HSV-2) Suppression to Prevent HIV Transmission

Who this might be right for
HIV InfectionHerpes Simplex, GenitalSexually Transmitted Diseases
University of Washington 3,408
Early research (Phase 1)Active Not RecruitingNCT05432583
What this trial is testing

A Clinical Trial in Healthy Volunteers and Volunteers With Recurrent Genital Herpes to Study the Safety, Tolerability, and Immune Responses After Vaccination With an Investigational Vaccine Designed to Prevent Genital Herpes Lesions

Who this might be right for
Genital Herpes Simplex Type 2
BioNTech SE 318
Early research (Phase 1)Study completedNCT06385327
What this trial is testing

Assess the Safety, Pharmacokinetics, and Antiviral Activity of ABI-5366 in Healthy Participants and Participants Seropositive for HSV-2 With Recurrent Genital Herpes

Who this might be right for
Recurrent Genital Herpes Simplex Type 2
Assembly Biosciences 115
Not applicableStudy completedNCT02910284
What this trial is testing

Long-term Follow-up of GEN-003-002 Subjects for Efficacy and Immunogenicity

Who this might be right for
Genital Herpes Simplex Type 2
Genocea Biosciences, Inc. 140
Early research (Phase 1)Enrolling By InvitationNCT07330440
What this trial is testing

A Phase I Study to Evaluate the Safety, Tolerability, and Immunogenicity of an mRNA Vaccine Against Herpes Simplex Virus Type 2 (HSV-2) Post-Vaccination

Who this might be right for
Genital Herpes
Changchun BCHT Biotechnology Co. 144
Post-approval studies (Phase 4)Study completedNCT00362297
What this trial is testing

Randomized Trial to Evaluate Suppressive Effect of High-Dose Acyclovir Versus Once-Daily Valacyclovir on Persons With HSV-2

Who this might be right for
Genital Herpes
University of Washington 31
Early research (Phase 1)Study completedNCT00274300
What this trial is testing

Safety Study of HSV2 DNA Vaccine to Treat Patients With Recurrent Genital Herpes Caused by HSV-2

Who this might be right for
HSV-2
PowderMed 36
Testing effectiveness (Phase 2)Study completedNCT06033261
What this trial is testing

MRNA-1608, a Herpes Simplex Virus -2 (HSV-2) Therapeutic Candidate Vaccine, in Healthy Adults 18 to 55 Years of Age With Recurrent HSV-2 Genital Herpes

Who this might be right for
Genital Herpes
ModernaTX, Inc. 303
Not applicableWithdrawnNCT04294030
What this trial is testing

NOWDx Test for the Diagnosis of Herpes Simplex Virus Type 2

Who this might be right for
HSV-2 InfectionHerpes Simplex Virus Infection
NOWDiagnostics, Inc.
Not applicableStudy completedNCT00803543
What this trial is testing

Effect of Valacyclovir in the Reduction of HSV-2 Recurrence and Shedding

Who this might be right for
HIVHIV Infections
University of Alabama at Birmingham 103
Testing effectiveness (Phase 2)Study completedNCT02300142
What this trial is testing

Rollover Trial for Placebo Subjects Previously Enrolled Into GEN-003-002 Study

Who this might be right for
Genital Herpes Simplex Type 2
Genocea Biosciences, Inc. 37
Early research (Phase 1)UnknownNCT05393440
What this trial is testing

First-in-human (FIH) Phase I Trial of BS-006 in Cervical Cancer

Who this might be right for
Uterine Cervical Neoplasms
Zhongnan Hospital 18
Testing effectiveness (Phase 2)Study completedNCT01047540
What this trial is testing

Safety and Efficacy Study for a New Antiviral Drug to Treat Genital Herpes Type 2

Who this might be right for
HSV-2
AiCuris Anti-infective Cures AG 156
Post-approval studies (Phase 4)Study completedNCT01346475
What this trial is testing

Randomized Trial to Evaluate Suppressive Effect of High-Dose Valacyclovir Versus Once-Daily Valacyclovir on Persons With HSV-2

Who this might be right for
Genital Herpes
University of Washington 50
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation